| Observed value | Changes from baseline | |||||||
---|---|---|---|---|---|---|---|---|---|
Placebo | Intervention | Placebo | Intervention | pb | |||||
Week 0 | Week 6 | pa | Week 0 | Week 6 | pa | ||||
Non-concentrated ADSC-CM (n = 17) | |||||||||
 HC | 164.76 ± 57.76 | 321.47 ± 120.09 | 0.006 | 132.29 ± 68.86 | 317.17 ± 118.89 | 0.000 | 156.70 ± 59.79 | 184.88 ± 119.63 | 0.563 |
 HD | 182.73 ± 64.35 | 352.71 ± 117.14 | 0.001 | 137.99 ± 68.47 | 351.11 ± 131.62 | 0.000 | 169.97 ± 158.95 | 213.12 ± 146.57 | 0.417 |
 VR | 36.71 ± 20.92 | 22.04 ± 12.98 | 0.003 | 43.05 ± 19.84 | 18.54 ± 11.76 | 0.001 |  − 14.67 ± 15.81 |  − 24.51 ± 22.53 | 0.150 |
 TR | 63.28 ± 20.92 | 77.95 ± 12.98 | 0.003 | 57.23 ± 19.48 | 81.42 ± 11.75 | 0.001 | 14.67 ± 15.81 | 24.19 ± 22.21 | 0.160 |
 MT | 0.041 ± 0.00 | 0.056 ± 0.01 | 0.000 | 0.042 ± 0.08 | 0.062 ± 0.01 | 0.004 | 0.016 ± 0.01 | 0.024 ± 0.01 | 0.120 |
 TFU | 115.29 ± 28.56 | 90.29 ± 35.32 | 0.005 | 178.23 ± 37.38 | 176.29 ± 41.74 | 0.847 |  − 25.00 ± 31.21 |  − 1.94 ± 40.86 | 0.220 |
Concentrated ADSC-CM (n = 20) | |||||||||
 HC | 125.65 ± 39.19 | 310.10 ± 104.70 | 0.000 | 130.50 ± 45.86 | 310.15 ± 104.70 | 0.000 | 184.45 ± 103.92 | 174.65 ± 119.89 | 0.784 |
 HD | 138.61 ± 42.74 | 343.30 ± 115.91 | 0.000 | 144.47 ± 50.78 | 337.82 ± 16.58 | 0.000 | 204.69 ± 14.45 | 193.34 ± 132.73 | 0.774 |
 VR | 43.69 ± 18.23 | 16.52 ± 7.66 | 0.000 | 38.66 ± 19.20 | 15.35 ± 7.75 | 0.000 |  − 27.16 ± 18.94 |  − 23.31 ± 20.16 | 0.568 |
 TR | 56.61 ± 18.22 | 83.47 ± 7.66 | 0.000 | 61.33 ± 19.20 | 84.65 ± 7.75 | 0.000 | 26.86 ± 18.81 | 23.32 ± 20.15 | 0.569 |
 MT | 0.045 ± 0.01 | 0.069 ± 0.13 | 0.000 | 0.046 ± 0.01 | 0.074 ± 0.01 | 0.000 | 0.024 ± 0.01 | 0.027 ± 0.01 | 0.577 |
 TFU | 93.00 ± 23.10 | 171.85 ± 35.79 | 0.000 | 94.95 ± 21.74 | 174.60 ± 38.57 | 0.000 | 78.85 ± 41.63 | 79.65 ± 46.34 | 0.955 |